| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| OUTPAT | OUTPAT_ICD10(L400) | Psoriasis vulgaris | 4960 | |
| OUTPAT | OUTPAT_ICD10(L405) | Arthropathic psoriasis (M07.0-M07.3*, M09.0*) | 2834 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(L40) | Psoriasis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 1496 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(L400) | Psoriasis vulgaris. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 1474 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(L405) | Arthropathic psoriasis (M07.0-M07.3*, M09.0*). Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 1437 | |
| INPAT | INPAT_ICD10(L405) | Arthropathic psoriasis (M07.0-M07.3*, M09.0*) | 977 | |
| OUTPAT | OUTPAT_ICD10(L403) | Pustulosis palmaris et plantaris | 947 | |
| INPAT | INPAT_ICD10(L400) | Psoriasis vulgaris | 889 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(L403) | Pustulosis palmaris et plantaris. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 729 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(L409) | Psoriasis, unspecified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 717 | |
| OUTPAT | OUTPAT_ICD10(L409) | Psoriasis, unspecified | 524 | |
| OUTPAT | OUTPAT_ICD10(L408) | Other psoriasis | 463 | |
| INPAT | INPAT_ICD8(69619) | Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris) | 419 | |
| INPAT | INPAT_ICD10(L409) | Psoriasis, unspecified | 309 | |
| INPAT | INPAT_ICD9(6961A) | Psoriasis and similar disorders, Other psoriasis | 301 | |
| OUTPAT | OUTPAT_ICD10(L404) | Guttate psoriasis | 296 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(L408) | Other psoriasis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 292 | |
| REIMB | REIMB_KELA(319)_ICD10(L400) | Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis), Psoriasis vulgaris | 250 | |
| INPAT | INPAT_ICD9(6960A) | Psoriatic arthropathy | 220 | |
| REIMB | REIMB_KELA(134)_ICD10(L400) | General erythroderma, Psoriasis vulgaris | 148 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(L404) | Guttate psoriasis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 131 | |
| INPAT | INPAT_ICD8(69600) | Psoriasis and similar disorders, Psoriatic arthropathy | 107 | |
| INPAT | INPAT_ICD10(L403) | Pustulosis palmaris et plantaris | 96 | |
| OUTPAT | OUTPAT_ICD10(L40) | Psoriasis | 96 | |
| INPAT | INPAT_ICD10(L408) | Other psoriasis | 91 | |
| OUTPAT | OUTPAT_ICD10(L401) | Generalized pustular psoriasis | 62 | |
| OUTPAT | OUTPAT_ICD10(L402) | Acrodermatitis continua | 45 | |
| INPAT | INPAT_ICD10(L404) | Guttate psoriasis | 37 | |
| INPAT | INPAT_ICD9(6961D) | Psoriasis and similar disorders, Other psoriasis | 30 | |
| INPAT | INPAT_ICD8(68693) | Other local infections of skin and subcutaneous tissue, Pustulosis palmo-plantaris | 28 | |
| INPAT | INPAT_ICD10(L401) | Generalized pustular psoriasis | 21 | |
| REIMB | REIMB_KELA(377)_ICD10(L400) | Apremilast and dimethyl fumarate (psoriasis), Psoriasis vulgaris | 21 | |
| INPAT | INPAT_ICD10(L40) | Psoriasis | 19 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(L401) | Generalized pustular psoriasis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 19 | |
| INPAT | INPAT_ICD9(6961B) | Psoriasis and similar disorders, Other psoriasis | 9 | |
| INPAT | INPAT_ICD10(L402) | Acrodermatitis continua | 8 | |
| INPAT | INPAT_ICD8(69610) | Psoriasis and similar disorders, Psoriasis pustulosa | 8 | |
| REIMB | REIMB_KELA(281)_ICD10(L400) | Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab, Psoriasis vulgaris | 8 | |
| DEATH | DEATH_ICD10(L405) | Arthropathic psoriasis (M07.0-M07.3*, M09.0*) | 7 | |
| REIMB | REIMB_KELA(313)_ICD10(L400) | Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases), Psoriasis vulgaris | 7 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(L402) | Acrodermatitis continua. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 5 |